Jonathan Wang
Senior Managing Director
medical sciences
PharmAbcine
Korea
Biography
Dr. Jonathan Wang, is a Senior Managing Director on the Asia Team in OrbiMed. Dr. Wang has nearly 20 years experience in the life sciences field, most recently as General Manager of Burrill & Company's Greater China Group. Prior to Burrill, Dr. Wang worked for WI Harper Group and Walden International, both ranked among the leading global venture capital firms operating in Asia. At WI Harper, Dr. Wang was a Managing Director, overseeing the firm's life sciences activities worldwide. During this time he co-founded Bridge Pharmaceuticals, a pioneering cross-Pacific pharmaceutical R&D services company.
Research Interest
Dr. Wang is Co-Founder and former Chairman of The BayHelix Group, a prestigious non-profit organization of Chinese life sciences business leaders. He holds a Ph.D. in Molecular Neurobiology from Columbia University, where he obtained scientific training under the supervision of Dr. Eric Kandel, a Nobel Laureate. Dr. Wang also earned an M.B.A. from Stanford University.
